Chronic Respiratory Conditions
{"Image DocumentName": "Chronic Respiratory Conditions", "Image ImageDescription": "Chronic Bronchitis: Positive systematic review found mg/day for 3-6 months significantly reduced exacerbations and decreased symptoms. Cystic Fibrosis: At lower doses (700mg/day) NAC acts as a mucolytic and general anti-inflammatory. At higher doses ( mg TID for 1-3 months) increased neutrophil GSH content, reduction in neutrophil influx in CF airways, sputum elastase activity and sputum IL-8 levels (attributed to decreased airway inflammation.) Inhibited MPO- significantly decreased lower respiratory airway oxidative stress. (Vasu et al 2011, Rushworth & Megson 2014.)", "Image XResolution": "37", "Image YResolution": "37", "Image ResolutionUnit": "Pixels/Centimeter", "Image Software": "SlidePlayer", "Image YCbCrPositioning": "Centered"}